Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 12;107(15):1226-1232.
doi: 10.1136/heartjnl-2020-318467.

Clinical outcome of COVID-19 in patients with adult congenital heart disease

Markus Schwerzmann  1 , Francisco Javier Ruperti-Repilado  2 , Helmut Baumgartner  3 , Berto Bouma  4 , Judith Bouchardy  5   6 , Werner Budts  7   8 , Laurence Campens  9 , Massimo Chessa  10 , Maria Jesús Del Cerro Marin  11 , Harald Gabriel  12 , Pastora Gallego  13 , Rocio Garcia-Orta  14 , Ana Elvira Gonzalez  15 , Annette Schophuus Jensen  16 , Magalie Ladouceur  17 , Berta Miranda-Barrio  18 , Marielle Morissens  19 , Agnes Pasquet  20 , Joaquín Rueda  21 , Annemien E van den Bosch  22 , Heleen Berdina van der Zwaan  23 , Daniel Tobler  24 , Matthias Greutmann  25 ; EPOCH
Collaborators, Affiliations

Clinical outcome of COVID-19 in patients with adult congenital heart disease

Markus Schwerzmann et al. Heart. .

Abstract

Aims: Patients with adult congenital heart disease (ACHD) are a potentially vulnerable patient cohort in case of COVID-19. Some cardiac defects may be associated with a poor COVID-19 outcome. Risk estimation in ACHD is currently based on expert opinion. The aim of this study was to collect clinical outcome data and to identify risk factors for a complicated course of COVID-19 in patients with ACHD.

Methods: Twenty-five ACHD centres in nine European countries participated in the study. Consecutive patients with ACHD diagnosed with COVID-19 presenting to one of the participating centres between 27 March and 6 June 2020 were included. A complicated disease course was defined as hospitalisation for COVID-19 requiring non-invasive or invasive ventilation and/or inotropic support, or a fatal outcome.

Results: Of 105 patients with a mean age of 38±13 years (58% women), 13 had a complicated disease course, of whom 5 died. In univariable analysis, age (OR 1.3, 95% CI 1.1 to 1.7, per 5 years), ≥2 comorbidities (OR 7.1, 95% CI 2.1 to 24.5), body mass index of >25 kg/m2 (OR 7.2, 95% CI 1.9 to 28.3) and cyanotic heart disease (OR 13.2, 95% CI 2.5 to 68.4) were associated with a complicated disease course. In a multivariable logistic regression model, cyanotic heart disease was the most important predictor (OR 60.0, 95% CI 7.6 to 474.0).

Conclusions: Among patients with ACHD, general risk factors (age, obesity and multiple comorbidities) are associated with an increased risk of complicated COVID-19 course. Congenital cardiac defects at particularly high risk were cyanotic lesions, including unrepaired cyanotic defects or Eisenmenger syndrome.

Keywords: congenital; heart defects.

PubMed Disclaimer

Conflict of interest statement

Competing interests: WB declared being proctor of Abbott and Occlutech.

Figures

Figure 1
Figure 1
Univariable significant COVID-19 risk factors in patients with adult congenital heart disease and the corresponding ORs. We propose to stratify patients based on age, number of comorbidities, weight and presence of a high-risk cardiac lesion (cyanotic heart disease). BMI, Body Mass Index.
See this image and copyright information in PMC

Comment in

References

    1. European Centre for Disease Prevention and Control . COVID-19 situation update for the EU/EEA and the UK. Available: https://www.ecdc.europa.eu/en/2019-ncov-background-disease
    1. Baumgartner H, Budts W, Chessa M, et al. . Recommendations for organization of care for adults with congenital heart disease and for training in the subspecialty of 'Grown-up Congenital Heart Disease' in Europe: a position paper of the Working Group on Grown-up Congenital Heart Disease of the European Society of Cardiology. Eur Heart J 2014;35:686–90. 10.1093/eurheartj/eht572 - DOI - PubMed
    1. Diller G-P, Kempny A, Alonso-Gonzalez R, et al. . Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 2015;132:2118–25. 10.1161/CIRCULATIONAHA.115.017202 - DOI - PubMed
    1. Oliver JM, Gallego P, Gonzalez AE, et al. . Risk factors for excess mortality in adults with congenital heart diseases. Eur Heart J 2017;38:1233–41. 10.1093/eurheartj/ehw590 - DOI - PubMed
    1. Raissadati A, Nieminen H, Haukka J, et al. . Late causes of death after pediatric cardiac surgery: a 60-year population-based study. J Am Coll Cardiol 2016;68:487–98. 10.1016/j.jacc.2016.05.038 - DOI - PubMed